-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Verrica Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
- Verrica Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$20.7M, a 13.4% increase year-over-year.
- Verrica Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$77.6M, a 59% decline year-over-year.
- Verrica Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$65.8M, a 209% decline from 2022.
- Verrica Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$21.3M, a 31.1% increase from 2021.
- Verrica Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$30.9M, a 23.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)